Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Tredegar 10% Owner William M. Gottwald Sells $268K of Stock
William M. Gottwald, 10% Owner, sold 33,334 shares of Tredegar Corp at $8.03 a share, worth $268K in total on Oct 20, 2026. Shares held after the trade: 292,286 (-10.2%).
Neptune Insurance Holdings Inc. reported a net income of $17.3 million for the third quarter of 2026, up from $11.5 million in the prior year period, driven by a 34% increase in commissions and fees revenue. For the nine months ended September 30, 2026, the company achieved a net income of $40.4 million compared to $33.1 million in 2025, despite a significant increase in employee compensation and benefits expenses.
Tredegar 10% Owner James T. Gottwald Sells $268K of Stock
James T. Gottwald, 10% Owner, sold 33,333 shares of Tredegar Corp at $8.03 a share, worth $268K in total on Oct 20, 2026. Shares held after the trade: 292,287 (-10.2%).
Enova International reported strong growth for the third quarter of 2026, with revenue increasing to $1.01 billion from $802.7 million in the prior year. Net income rose to $107.3 million, or $4.06 per diluted share, driven by a significant increase in loans and finance receivables which reached $6.60 billion.
NeOnc Technologies reported early clinical improvement in the first pediatric patient treated with its investigational intranasal NEO100 under a Compassionate Care program in Abu Dhabi. The company also announced a Memorandum of Understanding with the Department of Health – Abu Dhabi to cooperate on oncology and CNS therapeutic research.
DevvStream Legacy Corp. completed its business combination with XCF Global, Inc. on October 16, 2026, following its domestication as a Delaware corporation. Under the terms of the agreement, DevvStream shareholders received 1.1919 shares of XCF Class A common stock for each share held, resulting in the issuance of approximately 62.3 million XCF shares.
Jonathan Hyman, CTO, sold 295,000 shares of Braze, Inc. at $30.04 to $45.33 a share (average $44.81) in 2 transactions, worth $13.2M in total between Oct 15, 2026 and Oct 20, 2026. Shares held after the trade: 848,219 (-25.1%).
Investar Holding Corporation reported Q3 2026 net income of $11.1 million, or $0.74 per diluted share, representing a significant increase from $5.7 million in the prior year period. Results were driven by the acquisition of Wichita Falls Bancshares and a substantial improvement in net interest margin to 3.73%.
Term
Q3 2026
“I am extremely pleased with our third quarter results, which reflect both the significant impact of our transformational acquisition of Wichita Falls Bancshares, Inc. (“WFB”) and our continued execution of our strategy of consistent, quality earnings through the optimization of our balance sheet.”
John D’Angelo, President and Chief Executive Officer
“Our net interest margin improved substantially to 3.73%, a six basis point increase from previous quarter, and we posted strong results for our core metrics including diluted earnings per common share, return on average assets and efficiency ratio.”
John D’Angelo, President and Chief Executive Officer
Fermi 10% Owner Toby R. Neugebauer Sells $1.28M of Stock
Toby R. Neugebauer, 10% Owner, sold 420,749 shares of Fermi Inc. at $3.04 a share, worth $1.28M in total on Oct 20, 2026. Shares held after the trade: 91,188,910 (-0.5%).
Citigroup Inc. has elected James Flanagan to its Board of Directors and appointed him to the Audit Committee, effective October 21, 2026. Mr. Flanagan, a former Vice Chairman and COO of PricewaterhouseCoopers (PwC), will also join the board of Citibank, N.A. He brings extensive experience in risk, operations, and accounting to the board and will be compensated as a non-employee director.
National Healthcare Properties announced the automatic conversion of all 44,275,000 outstanding shares of Class A common stock into regular common stock on a one-for-one basis. The conversion occurred 180 days after the company's IPO prospectus date as required by its charter, resulting in 72,910,570 total shares of common stock outstanding. The event simplifies the company's capital structure by eliminating the Class A designation while maintaining identical economic and voting rights for shareholders.
Lockheed Martin reported net earnings of $1.85 billion for the quarter ended September 27, 2026, an increase from $1.62 billion in the prior year period. Total sales grew to $20.7 billion, driven primarily by product sales, while the company maintained a strong cash position with $6.9 billion in net cash provided by operating activities for the first nine months of the year.
Advasa Holdings' largest stockholder, Asamitsu Kosugi, has expressed his intention to surrender 97,413,140 shares of common stock to the company for no consideration. This proposed forfeiture would result in the cancellation of approximately 20% of the company's total outstanding common stock. The transaction is intended to reduce the overall share count and is subject to final documentation and corporate approvals.
Disc Medicine closed an underwritten public offering of 6,000,000 shares of common stock at a price of $75.00 per share, generating gross proceeds of $450 million. The company expects the net proceeds to extend its cash runway into 2030, supporting the clinical development and potential commercialization of its hematologic disease treatments, including bitopertin.
Intuitive Machines appointed Dr. Christopher Scolese to its Board of Directors, effective October 22, 2026, filling a vacancy created by the resignation of Michael Blitzer. Dr. Scolese, a former Director of the National Reconnaissance Office and NASA Goddard Space Flight Center, will serve as a Class II director and Chair of the Conflicts Committee.
XCF Global M&A Deal with Southern Energy Renewables Inc. and DevvStream Corp.
XCF Global, Inc. completed its previously announced all-stock business combination with Southern Energy Renewables and DevvStream Corp. on October 16, 2026. The transaction creates a vertically integrated alternative energy platform, with former Southern and DevvStream equity holders owning approximately 20.0% and 10.43% of the combined company, respectively.
Counterparty
Southern Energy Renewables Inc. and DevvStream Corp.
“Today marks an important milestone for XCF as we bring together renewable fuel production, new technology pathways and environmental-asset optimization capabilities on one vertically integrated platform. This combination expands our capabilities and supports our strategy to reduce emissions, enhance energy security and resilience, promote alternative uses for domestic agricultural resources, locate production closer to demand and pursue additional value across the alternative renewable fuels chain across our growing glob”
Chris Cooper, Chief Executive Officer of XCF Global
Fiona Tan, CTO, sold 8,000 shares of Wayfair Inc. at $115.00 a share, worth $920K in total on Oct 20, 2026. Shares held after the trade: 196,698 (-3.9%).
Kaiser Aluminum reported a significant increase in net cash provided by operating activities to $248.1 million for the nine months ended September 30, 2026, compared to $132.0 million in the prior year. The company early adopted ASU 2025-09 regarding hedge accounting and maintained a strong liquidity position with cash and restricted cash ending at $136.9 million.
Corebridge Financial 10% Owner Nippon Life Insurance Co Buys $6.77M of Stock
Nippon Life Insurance Co, 10% Owner, bought 193,357 shares of Corebridge Financial, Inc. at $35.01 a share, worth $6.77M in total on Oct 20, 2026. Shares held after the trade: 130,203,484 (+0.1%).
Atlantic American Corporation received a staff delisting determination from Nasdaq on October 16, 2026, due to its failure to timely file its 2025 Annual Report and two subsequent 2026 Quarterly Reports. The company has since filed its 2025 Form 10-K and intends to appeal the delisting notice by requesting a hearing before a Nasdaq Hearings Panel to stay the suspension of its common stock. The company is working to file the remaining delinquent reports to regain compliance with Nasdaq Listing Rule 5250(c)(1).
Tenon Medical entered into waivers with an institutional investor and its placement agent to permit an increase in the capacity of its existing 'at-the-market' (ATM) offering program. As consideration for the waiver, the company issued a new warrant to the investor for 125,000 shares of common stock at an exercise price of $5.02 per share.
Stark Novus Financial Inc. filed a Certificate of Correction to nullify a previously reported charter amendment after discovering it failed to receive the required majority vote of outstanding shares at the 2025 Annual Meeting. Consequently, the company's existing NOL Protective Provisions, which restrict stock transfers for 4.5% or greater shareholders to preserve tax benefits, remain in effect through the 2027 annual meeting.
Janel Signs $17M M&A Deal with EnCor Biotechnology Inc.
Janel Corporation, through its subsidiary Antibodies Incorporated, acquired 100% of EnCor Biotechnology Inc. for $17 million, consisting of $11.96 million in cash and a $5.04 million subordinated promissory note. The acquisition of the Florida-based biotechnology company was funded through cash on hand and an $11 million draw from an expanded senior credit facility.
Village Farms International Executive Compensation
Village Farms International entered into a new employment agreement with Stephen C. Ruffini as Executive Vice President, Mergers & Acquisitions, effective October 16, 2026. The agreement provides for an annual base salary of $400,000, a target bonus of 50% of base salary, and eligibility for share-based compensation awards. The contract runs through May 31, 2028, and includes an 18-month salary continuation provision in the event of termination without cause or resignation for good reason.
Bronislaw E. Masojada resigned from the Board of Directors and its Audit and Compensation Committees, effective October 21, 2026. The resignation is due to his election as the 698th Lord Mayor of the City of London and is not the result of any disagreement with the company.
Auddia Signs $3.31M M&A Deal with Thramann Holdings, LLC
Auddia Inc. amended its interim bridge funding agreements for the target companies involved in its pending merger with McCarthy Finney, Inc. and Thramann Holdings. The amendment increases the maximum aggregate funding available to the four target entities (Thramann Holdings, LT350, Influence Healthcare, and Voyex) to $3.305 million to provide working capital while the merger remains pending.
Kilroy Realty Corporation reported Q3 2026 financial results, highlighted by strong leasing momentum with over 800,000 square feet of long-term leases signed. The company updated its full-year 2026 FFO guidance to a range of $3.55 to $3.59 per diluted share, reflecting fundamental improvements across its West Coast markets.
Term
Q3 2026
“Momentum in our West Coast markets continued to accelerate in the third quarter, with over 800,000 square feet of long-term leases signed, representing one of the Company’s highest quarterly leasing volumes since 2019. The breadth of activity was particularly notable, as we recorded sequential leased occupancy gains across all five of our regions and strong re-leasing spreads, driven by activity from a wide variety of users and industries. Looking ahead, our high-quality portfolio, solid balance sheet, and nimble approach position us well to capitalize on the real-time fundamental improvements we are seeing across our regions.”
Rapport Therapeutics Director Paul M. Silva Buys $99.6K of Stock
Paul M. Silva, Director, bought 3,680 shares of Rapport Therapeutics, Inc. at $27.07 a share, worth $99.6K in total on Oct 22, 2026. Shares held after the trade: 3,680.
Rapport Therapeutics Director Wendy B. Young Buys $100K of Stock
Wendy B. Young, Director, bought 3,789 shares of Rapport Therapeutics, Inc. at $26.39 a share, worth $100K in total on Oct 22, 2026. Shares held after the trade: 13,289 (+39.9%).
Rapport Therapeutics Director Steven M. Paul Buys $974K of Stock
Steven M. Paul, Director, bought 35,714 shares of Rapport Therapeutics, Inc. at $27.28 a share, worth $974K in total on Oct 22, 2026. Shares held after the trade: 77,380 (+85.7%).